Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/40675
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPINCELA LINS, Paula-
dc.contributor.authorPIRLET, Elke-
dc.contributor.authorSzymonik, Michal-
dc.contributor.authorBRONCKAERS, Annelies-
dc.contributor.authorNelissen, Inge-
dc.date.accessioned2023-08-04T06:49:46Z-
dc.date.available2023-08-04T06:49:46Z-
dc.date.issued2023-
dc.date.submitted2023-08-03T15:10:58Z-
dc.identifier.citationTRENDS IN BIOTECHNOLOGY, 41 (7) , p. 965 -981-
dc.identifier.urihttp://hdl.handle.net/1942/40675-
dc.description.abstractMesenchymal stromal cells (MSCs) are a promising therapy for various diseases ranging from ischemic stroke to wound healing and cancer. Their therapeutic effects are mainly mediated by secretome-derived paracrine factors, with extracellular vesicles (EVs) proven to play a key role. This has led to promising research on the potential of MSC-EVs as regenerative, off-the-shelf therapeutic agents. However, the translation of MSC-EVs into the clinic is hampered by the poor scalability of their production. Recently, new advanced methods have been developed to upscale MSC cultivation and EV production yields, ranging from new cell culture devices to priming procedures. This review gives an overview of these innovative strategies for manufacturing MSC-EVs.-
dc.language.isoen-
dc.publisherCELL PRESS-
dc.subject.otherextracellular vesicles-
dc.subject.othermesenchymal stromal cells-
dc.subject.otherbioreactor-
dc.subject.otherupscaled manufacturing-
dc.titleManufacture of extracellular vesicles derived from mesenchymal stromal cells-
dc.typeJournal Contribution-
dc.identifier.epage981-
dc.identifier.issue7-
dc.identifier.spage965-
dc.identifier.volume41-
local.bibliographicCitation.jcatA1-
local.publisher.place50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA-
local.type.refereedRefereed-
local.type.specifiedReview-
dc.identifier.doi10.1016/j.tibtech.2023.01.003-
dc.identifier.isiWOS:001027534500001-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0167779923000203-
local.provider.typeris-
local.uhasselt.internationalno-
item.accessRightsRestricted Access-
item.fulltextWith Fulltext-
item.validationecoom 2024-
item.contributorPINCELA LINS, Paula-
item.contributorPIRLET, Elke-
item.contributorSzymonik, Michal-
item.contributorBRONCKAERS, Annelies-
item.contributorNelissen, Inge-
item.fullcitationPINCELA LINS, Paula; PIRLET, Elke; Szymonik, Michal; BRONCKAERS, Annelies & Nelissen, Inge (2023) Manufacture of extracellular vesicles derived from mesenchymal stromal cells. In: TRENDS IN BIOTECHNOLOGY, 41 (7) , p. 965 -981.-
crisitem.journal.issn0167-7799-
crisitem.journal.eissn1879-3096-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
1-s2.0-S0167779923000203-main.pdf
  Restricted Access		Published version2.34 MBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

40
checked on Oct 6, 2025

WEB OF SCIENCETM
Citations

37
checked on Oct 2, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.